Maternal Mthfd1 disruption impairs fetal growth but does not cause neural tube defects in mice

American Journal of Clinical Nutrition

Volumn 95, Issue 4, 2012, Pages 882-891

  Beaudin, Anna E ^a   Perry, Cheryll A ^a   Stabler, Sally P ^b   Allen, Robert H ^b   Stover, Patrick J ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CYSTATHIONINE; DIMETHYLGLYCINE; FOLIC ACID; HOMOCYSTEINE; HYPOXANTHINE; METHIONINE; MTHFD1 PROTEIN; PROTEIN; SARCOSINE; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DNA POLYMORPHISM; EMBRYO; ENZYME ACTIVITY; EXENCEPHALY; FEMALE; FERTILITY; FETUS GROWTH; GENE EXPRESSION; GENOTYPE; INTRAUTERINE GROWTH RETARDATION; MALE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PREGNANCY OUTCOME; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

AMINOHYDROLASES; ANIMALS; CHOLINE; CHOLINE DEFICIENCY; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; EMBRYO LOSS; FEMALE; FETAL GROWTH RETARDATION; FOLIC ACID; FOLIC ACID DEFICIENCY; FORMATE-TETRAHYDROFOLATE LIGASE; GENES, LETHAL; HETEROZYGOTE; HOMOCYSTEINE; HYPOXANTHINE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); MICE; MICE, MUTANT STRAINS; MULTIENZYME COMPLEXES; MUTAGENESIS, INSERTIONAL; NEURAL TUBE DEFECTS; PREGNANCY;

MUS;

EID: 84859025355     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.030783     Document Type: Article

References (43)

1. Steegers-Theunissen RP, Van Iersel CA, Peer PG, Nelen WL, Steegers EA. Hyperhomocysteinemia, pregnancy complications, and the timing of investigation. Obstet Gynecol 2004;104:336-43. (Pubitemid 40458881)
2. George L, Mills JL, Johansson AL, Nordmark A, Olander B, Granath F, Cnattingius S. Plasma folate levels and risk of spontaneous abortion. JAMA 2002;288:1867-73. (Pubitemid 35168142)
3. Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000;71:1295S-303S. (Pubitemid 30230532)
4. Wen SW, Chen XK, Rodger M, White RR, Yang Q, Smith GN, Sigal RJ, Perkins SL, Walker MC. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 2008: 198:45.e1-7.
5. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 2000;71:962-8. (Pubitemid 30176580)
6. Burke G, Robinson K, Refsum H, Stuart B, Drumm J, Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med 1992;326:69-70.
7. Baksu A, Taskin M, Goker N, Baksu B, Uluocak A. Plasma homocysteine inlate pregnancies complicated with preeclampsia and in newborns. Am J Perinatol 2006;23:31-5. (Pubitemid 43214401)
8. Siega-Riz AM, Savitz DA, Zeisel SH, Thorp JM, Herring A. Second trimester folate status and preterm birth. Am J Obstet Gynecol 2004; 191:1851-7. (Pubitemid 39601487)
9. Czeizel AE, Dudas I. Prevention ofthe first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5. (Pubitemid 23003073)
10. MRC. Prevention ofneural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338:131-7.
11. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006;28:680-9.
12. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, Arbour L. Changes infrequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Public Health 2008;99:271-5.
13. Canfield MA, Collins JS, Botto LD, Williams LJ, Mai CT, Kirby RS, Pearson K, Devine O, Mulinare J. Changes inthe birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 2005;73:679-89. (Pubitemid 41572010)
14. Chevrier C, Perret C, BahuauM, Zhu H, Nelva A, Herman C, Francannet C, Robert-Gnansia E, Finnell RH, Cordier S. Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A 2007;143:248-57. (Pubitemid 46212215)
15. Yazdy MM, Honein MA, Xing J. Reduction inorofacial clefts following folic acid fortification of the U.S. grain supply. Birth Defects Res A Clin Mol Teratol 2007;79:16-23. (Pubitemid 46053406)
16. van Rooij IA, Vermeij-Keers C, Kluijtmans LA, Ocke MC, Zielhuis GA, Goorhuis-Brouwer SM, van der Biezen JJ, Kuijpers-Jagtman AM, Steegers-Theunissen RP. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate? Am J Epidemiol 2003;157:583-91. (Pubitemid 36368528)
17. Relton CL, Wilding CS, Laffling AJ, Jonas PA, Burgess T, Binks K, Tawn EJ, Burn J. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 2004;81:273-81. (Pubitemid 38429990)
18. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9. (Pubitemid 26006560)
19. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, et al. A common mutation inthe 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002;99:5606-11. (Pubitemid 34411596)
20. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix BM, Rosenblatt DS, Gravel RA, Forbes P, et al. Genetic polymorphisms inmethylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7. (Pubitemid 29201082)
21. Pei L, Zhu H, Zhu J, Ren A, Finnell RH, Li Z. Genetic variation ofinfant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China. Ann Epidemiol 2006;16:352-6.
22. van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, Daniels O, Blom HJ. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006;27:981-7.
23. Christensen KE, MacKenzie RE. Mitochondrial one-carbon metabolism isadapted to the specific needs of yeast, plants and mammals. Bioessays 2006;28:595-605. (Pubitemid 43886185)
24. Fox JT, Stover PJ. Folate-mediated one-carbon metabolism. Vitam Horm 2008;79:1-44.
25. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O'Leary VB, Parle-McDermott A, Scott JM, et al. A polymorphism, R653Q, inthe trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is amaternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002;71:1207-15. (Pubitemid 35305240)
26. Parle-McDermott A, Kirke PN, Mills JL, Molloy AM, Cox C, O'Leary VB, Pangilinan F, Conley M, Cleary L, Brody LC, et al. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet 2006;14:768-72. (Pubitemid 43797275)
27. De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, Cama A, Capra V. Evaluation of amethylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk. J Hum Genet 2006; 51:98-103. (Pubitemid 43155452)
28. Mills JL, Molloy AM, Parle-McDermott A, Troendle JF, Brody LC, Conley MR, Cox C, Pangilinan F, Orr DJ, Earley M, et al. Folate-related gene polymorphisms asrisk factors for cleft lip and cleft palate. Birth Defects Res A Clin Mol Teratol 2008;82:636-43.
29. Christensen KE, Rohlicek CV, Andelfinger GU, Michaud J, Bigras JL, Richter A, Mackenzie RE, Rozen R. The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects. Hum Mutat 2009;30:212-20.
30. Parle-McDermott A, Mills JL, Kirke PN, Cox C, Signore CC, Kirke S, Molloy AM, O'Leary VB, Pangilinan FJ, O'Herlihy C, et al. MTHFD1 R653Q polymorphism isa maternal genetic risk factor for severe abruptio placentae. Am J Med Genet A 2005;132:365-8. (Pubitemid 40175585)
31. Parle-McDermott A, Pangilinan F, Mills JL, Signore CC, Molloy AM, Cotter A, Conley M, Cox C, Kirke PN, Scott JM, et al. A polymorphism inthe MTHFD1 gene increases a mother's risk of having an unexplained second trimester pregnancy loss. Mol Hum Reprod 2005;11: 477-80. (Pubitemid 41258233)
32. Furness DL, Fenech MF, Khong YT, Romero R, Dekker GA. Onecarbon metabolism enzyme polymorphisms and uteroplacental insufficiency. Am J Obstet Gynecol 2008:199:276.e1-8.
33. MacFarlane AJ, Perry CA, Girnary HH, Gao D, Allen RH, Stabler SP, Shane B, Stover PJ. Mthfd1 isan essential gene in mice and alters biomarkers of impaired one-carbon metabolism. J Biol Chem 2009; 284:1533-9.
34. Brosnan JT, Jacobs RL, Stead LM, Brosnan ME. Methylation demand: akey determinant of homocysteine metabolism. Acta Biochim Pol 2004;51:405-13. (Pubitemid 38969303)
35. McClive PJ, Sinclair AH. Rapid DNA extraction and PCR-sexing of mouse embryos. Mol Reprod Dev 2001;60:225-6. (Pubitemid 32847133)
36. Suh JR, Oppenheim EW, Girgis S, Stover PJ. Purification and properties of a folate-catabolizing enzyme. J Biol Chem 2000;275:35646-55.
37. Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-13. (Pubitemid 23172927)
38. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism 1993;42:978-88. (Pubitemid 23230428)
39. Patel H, Pietro ED, MacKenzie RE. Mammalian fibroblasts lacking mitochondrial NAD+-dependent methylenetetrahydrofolate dehydrogenasecyclohydrolase are glycine auxotrophs. J Biol Chem 2003;278:19436-41. (Pubitemid 36799339)
40. Christensen KE, Patel H, Kuzmanov U, Mejia NR, MacKenzie RE. Disruption of the mthfd1 gene reveals a monofunctional 10-formyltetrahydrofolate synthetase in mammalian mitochondria. J Biol Chem 2005;280:7597-602. (Pubitemid 40349652)
41. Nureddin A, Epsaro E, Kiessling AA. Purines inhibit the development of mouse embryos in vitro. J Reprod Fertil 1990;90:455-64. (Pubitemid 20386481)
42. Downs SM, Dow MP. Hypoxanthine-maintained two-cell block inmouse embryos: dependence on glucose and effect of hypoxanthine phosphoribosyltransferase inhibitors. Biol Reprod 1991;44:1025-39.
43. Heid MK, Bills ND, Hinrichs SH, Clifford AJ. Folate deficiency alone does not produce neural tube defects in mice. J Nutr 1992;122:888-94.